Skip to main content

Table 1 Expression of podoplanin and moesin at invasive tumor front of 84 oral squamous cell carcinoma, according to clinical data and follow-up. A.C. Camargo Cancer Hospital, São Paulo, Brazil, 1963 to 2012

From: Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer

Variable Moesin p Podoplanin p
Weak Strong Weak Strong
N % N % N % N %
Gender
 Male 35 87.5 37 84.1 0.656 45 91.8 27 77.1 0.058
 Female 5 12.5 7 15.9 4 8.2 8 22.9
Age
  ≤ 58 years 22 55 20 45.5 0.382 24 49 18 51.4 0.825
  > 58 years 18 45 24 54.5 25 51 17 48.6
 White 39 97,5 41 93.2 0.618 46 93.9 34 97.1 0.637
 Non-white 1 2,5 3 6.8 3 6.1 1 2.9
Tobaccoa
 Yes 31 93.9 40 95.2 0.999 43 95.6 28 93.3 0.999
 No 2 6.1 2 4.8 2 4.4 2 6.7
Alcohola
 Yes 26 76.5 31 73.8 0.790 32 71.1 25 80.6 0.346
 No 8 23.5 11 26.2 13 28.9 6 19.4
T Stage
 T2 25 62.5 25 56.8 0.596 27 55.1 23 65.7 0.329
 T3 15 37.5 19 43.2 22 44.9 12 34.3
N Stage
 N0 22 55 21 47.7 0.505 24 49 19 54.3 0.631
 N+ 18 45 23 52.3 25 51 16 45.7
Lymph Node Involvement
 No 2 5 1 2.3 0.679 1 2 2 5.7 0.669
 Ipsilateral 30 75 36 81.8 39 79.6 27 77.1
 Contralateral 8 20 7 15.9 9 18.4 6 17.1
Radiotherapy
 Yes 20 50 17 38.6 0.295 21 42.9 26 74.3 0.004
 No 20 50 27 61.4 28 57.1 9 25.7
Recurrence
 Yes 22 55 21 47.7 0.505 26 53.1 15 42.9 0.356
 No 18 45 23 52.3 23 46.9 20 57.1
Second Tumor
 Yes 10 25 4 9.1 0.061 6 12.2 8 22.9 0.198
 No 30 75 40 90.0 43 87.8 27 77.1
TOTAL   40 100 44 100   36 100 55 100  
  1. N: Number of tumors; p: value obtained by chi-squares test or Fischer’s exact test
  2. aExcluded patients with lost records
  3. p<0.05 was considered statistically significant